These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 38650086

  • 1. Leukotriene receptor antagonists as adjuvant therapy of antihistamines in chronic urticaria: a systematic review and meta-analysis.
    Ribeiro Gonçalves O, Ribeiro VEA, Galvão MTL, Silva ROS, Sobral MVS, Kojima GSA, Freitas JLR, Soares VG, de Azevedo BB, Baima de Melo C.
    Int J Dermatol; 2024 Sep; 63(9):1140-1144. PubMed ID: 38650086
    [Abstract] [Full Text] [Related]

  • 2. Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials.
    Rayner DG, Liu M, Chu AWL, Chu X, Guyatt GH, Oykhman P, Cao DJ, Moellman J, Ben-Shoshan M, Baker DR, Waserman S, Lang D, Sheikh J, Mathur SK, Beck LA, Khan DA, Oliver ET, Asiniwasis RN, Cole EF, Wheeler KE, Runyon L, Chan J, Trayes KP, Eftekhari S, Gardner DD, Winders T, Saini SS, Bernstein JA, Chu DK.
    J Allergy Clin Immunol; 2024 Oct; 154(4):996-1007. PubMed ID: 38852861
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S, Orcen C, Church MK, Kocaturk E.
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [Abstract] [Full Text] [Related]

  • 4. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
    Matterne U, Böhmer MM, Weisshaar E, Jupiter A, Carter B, Apfelbacher CJ.
    Cochrane Database Syst Rev; 2019 Jan 22; 1(1):CD012167. PubMed ID: 30666626
    [Abstract] [Full Text] [Related]

  • 5. Oral Antihistamines Alone vs in Combination with Leukotriene Receptor Antagonists for Allergic Rhinitis: A Meta-analysis.
    Liu G, Zhou X, Chen J, Liu F.
    Otolaryngol Head Neck Surg; 2018 Mar 22; 158(3):450-458. PubMed ID: 29337654
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
    Fukunaga A, Oda Y, Washio K, Omori T, Kakei Y, Hide M, Nishigori C.
    Trials; 2020 Jan 06; 21(1):23. PubMed ID: 31906999
    [Abstract] [Full Text] [Related]

  • 7. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.
    Wilson AM, O'Byrne PM, Parameswaran K.
    Am J Med; 2004 Mar 01; 116(5):338-44. PubMed ID: 14984820
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS.
    J Dermatolog Treat; 2009 Mar 01; 20(4):194-7. PubMed ID: 19085267
    [Abstract] [Full Text] [Related]

  • 9. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials.
    Rodrigo GJ, Yañez A.
    Ann Allergy Asthma Immunol; 2006 Jun 01; 96(6):779-86. PubMed ID: 16802764
    [Abstract] [Full Text] [Related]

  • 10. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
    Ferrer M, Jáuregui I, Bartra J, Dávila I, del Cuvillo A, Montoro J, Mullol J, Valero A, Sastre J.
    Br J Dermatol; 2009 Apr 01; 160(4):823-7. PubMed ID: 19120332
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials.
    Xiao X, Xue P, Shi Y, Yao J, Cao W, Zhang L, Zou Z, Zhou S, Wang C, Chen M, Jin R, Li Y, Zheng Q.
    BMC Pharmacol Toxicol; 2023 Apr 06; 24(1):23. PubMed ID: 37024900
    [Abstract] [Full Text] [Related]

  • 15. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
    Hon KL, Li JTS, Leung AKC, Lee VWY.
    Expert Opin Pharmacother; 2021 Mar 06; 22(4):497-509. PubMed ID: 32990110
    [Abstract] [Full Text] [Related]

  • 16. Factors Associated With Refractoriness to an Up to Fourfold Dosage of Antihistamines in Isolated Chronic Spontaneous Urticaria.
    Wongjirattikarn R, Chaowattanapanit S, Foocharoen C, Sawanyawisuth K, Choonhakarn C, Julanon N, Utchariyaprasit E.
    J Cutan Med Surg; 2022 Mar 06; 26(6):593-599. PubMed ID: 36172833
    [Abstract] [Full Text] [Related]

  • 17. Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
    Bei W, Qian J, Zilu Q, Kai C, Ruili J, Feng H, Liuqing C.
    Int Immunopharmacol; 2023 Oct 06; 123():110577. PubMed ID: 37567010
    [Abstract] [Full Text] [Related]

  • 18. H1-antihistamines for chronic spontaneous urticaria.
    Sharma M, Bennett C, Cohen SN, Carter B.
    Cochrane Database Syst Rev; 2014 Nov 14; 2014(11):CD006137. PubMed ID: 25397904
    [Abstract] [Full Text] [Related]

  • 19. Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.
    Grekowitz E, Metz M, Altrichter S, Bauer A, Brockow K, Heine G, Lionnet L, Saday KK, Hultsch T, Søerensen OE, Maurer M.
    Br J Dermatol; 2024 May 17; 190(6):825-835. PubMed ID: 38308655
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria.
    Khan S, Lynch N.
    Inflamm Allergy Drug Targets; 2012 Jun 17; 11(3):235-43. PubMed ID: 22452602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.